Is Carisma Therapeutics, Inc. (CARM) a Buy, Sell, or Hold?
OTC : CARM
Carisma Therapeutics, Inc. — Institutional Ownership
$0.0025 USD
$0 (0.0%)
- Volume
- 10.3K
- Average Volume
- 28.48K
- Market Capitalization
- $104.61K
- P/E Ratio
- 0.00
- Dividend Yield
- 0.00%
- Price Target
- $6.00
- Year High
- $0.56
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.86
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2025-09-02 | HealthCap VII, L.P. | - | 0.00% |
| 2025-09-02 | HealthCap VII GP LLC | - | 0.00% |
| 2025-08-29 | HealthCap VII, L.P. | 2.01M | 4.80% |
| 2025-08-29 | HealthCap VII GP LLC | 2.01M | 4.80% |
| 2025-08-21 | HealthCap VII, L.P. | 2.72M | 6.50% |
| 2025-08-21 | HealthCap VII GP LLC | 2.72M | 6.50% |
| 2025-04-25 | AbbVie Biotechnology Ltd. | 1.86M | 4.40% |
| 2024-03-13 | AbbVie Biotechnology Ltd. | 2.75M | 6.80% |
CARM Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2024-12-31 | $0.42 | 41.46M | $17.36M | $17.91M | $2.48M | $1.93M |
| 2023-12-31 | $2.93 | 33.52M | $98.23M | $77.6M | $3.12M | $23.74M |
| 2022-12-31 | $12.19 | 40.26M | $490.73M | $24.19M | $40.16M | $506.7M |
| 2021-12-31 | $16.30 | 9.12M | $148.59M | $162.64M | $2.63M | -$11.41M |
| 2020-12-31 | $27.00 | 5.91M | $159.6M | $55.39M | -$ | $104.21M |
| 2019-12-31 | $20.80 | 4.55M | $94.56M | $48.12M | -$ | $46.44M |
| 2018-12-31 | $28.40 | 3.09M | $87.73M | $50.42M | -$ | $37.31M |
| 2017-12-31 | $16.22 | 1.3M | $21.17M | $14.68M | -$ | $6.49M |
| 2016-12-31 | $38.20 | 1.05M | $40.26M | $25.34M | -$ | $14.92M |
| 2015-12-31 | $60.20 | 949.65K | $57.17M | $36.08M | $13.9M | $34.99M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-09-30 | $0.27 | 41.79M | $11.45M | $2.78M | $762K | $9.43M |
| 2025-06-30 | $0.39 | 41.79M | $16.36M | $2M | $1.7M | $16.07M |
| 2025-03-31 | $0.31 | 41.77M | $12.95M | $7.74M | $2.32M | $7.53M |
| 2024-12-31 | $0.42 | 41.46M | $17.36M | $17.91M | $2.48M | $1.93M |
| 2024-09-30 | $0.98 | 41.54M | $40.78M | $26.88M | $3.32M | $17.22M |
| 2024-06-30 | $1.67 | 41.54M | $69.38M | $40.36M | $3.76M | $32.78M |
| 2024-03-31 | $2.09 | 40.94M | $85.56M | $56.52M | $7.49M | $36.54M |
| 2023-12-31 | $2.93 | 40.39M | $118.35M | $77.6M | $3.12M | $43.87M |
| 2023-09-30 | $4.23 | 40.29M | $170.41M | $83.13M | $2.75M | $90.02M |
| 2023-06-30 | $8.77 | 40.26M | $353.06M | $76.35M | $5.23M | $281.94M |
| 2023-03-31 | $3.10 | 40.26M | $124.8M | $62.78M | $5.47M | $67.49M |
| 2022-12-31 | $12.19 | 40.26M | $490.73M | $24.19M | $40.16M | $506.7M |